Small particle aerosol inoculation of cowpox Brighton Red in rhesus monkeys results in a severe respiratory disease

Virology
Reed F JohnsonPeter B Jahrling

Abstract

Cowpox virus (CPXV) inoculation of nonhuman primates (NHPs) has been suggested as an alternate model for smallpox (Kramski et al., 2010, PLoS One, 5, e10412). Previously, we have demonstrated that intrabronchial inoculation of CPXV-Brighton Red (CPXV-BR) into cynomolgus monkeys resulted in a disease that shared many similarities to smallpox; however, severe respiratory tract disease was observed (Smith et al., 2011, J. Gen. Virol.). Here we describe the course of disease after small particle aerosol exposure of rhesus monkeys using computed tomography (CT) to monitor respiratory disease progression. Subjects developed a severe respiratory disease that was uniformly lethal at 5.7 log10 PFU of CPXV-BR. CT indicated changes in lung architecture that correlated with changes in peripheral blood monocytes and peripheral oxygen saturation. While the small particle aerosol inoculation route does not accurately mimic human smallpox, the data suggest that CT can be used as a tool to monitor real-time disease progression for evaluation of animal models for human diseases.

References

Oct 6, 1990·Lancet·A M Eis-HübingerC P Czerny
Dec 23, 1999·The Journal of Infectious Diseases·M BrayJ W Huggins
Dec 14, 2001·Laboratory Investigation; a Journal of Technical Methods and Pathology·G M ZauchaL Hensley
Aug 9, 2003·Journal of Clinical Microbiology·M Sofi IbrahimPeter B Jahrling
Dec 13, 2003·Journal of Pharmacological and Toxicological Methods·Justin M Hartings, Chad J Roy
Mar 5, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mike Bray, Mark Buller
Apr 14, 2004·Journal of Virology·J W HooperP B Jahrling
Oct 13, 2004·Proceedings of the National Academy of Sciences of the United States of America·Peter B JahrlingJohn W Huggins
Dec 4, 2004·Nature Medicine·Thomas W Geisbert, Peter B Jahrling
Jan 6, 2005·The Journal of Infectious Diseases·Yvette Edghill-SmithGenoveffa Franchini
May 28, 2005·Journal of Virology·Koert J StittelaarAlbert D M E Osterhaus
Jun 14, 2005·Nature Medicine·Yvette Edghill-SmithGenoveffa Franchini
Sep 28, 2005·The Journal of General Virology·Anna M LikosInger K Damon
Mar 16, 2006·Veterinary Pathology·K Mätz-RensingF-J Kaup
May 19, 2006·Emerging Infectious Diseases·Byron E E MartinaAlbert D M E Osterhaus
Feb 9, 2007·Journal of Virology·April Keim ParkerR Mark L Buller
Mar 5, 2008·Current Opinion in Infectious Diseases·Rengina M VorouIoannis N Pierroutsakos
Aug 6, 2008·Proceedings of the National Academy of Sciences of the United States of America·Patricia L EarlBernard Moss
Apr 8, 2009·Antimicrobial Agents and Chemotherapy·John HugginsDennis Hruby
Aug 5, 2010·Veterinary Pathology·J L ChapmanJ W Raymond
Sep 2, 2010·Proceedings of the National Academy of Sciences of the United States of America·Anne W RimoinJean-Jacques Muyembe
Jan 12, 2011·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Jonathan B Tucker
Sep 24, 2011·The Journal of General Virology·Alvin L SmithReed F Johnson
Oct 13, 2011·Advances in Preventive Medicine·Paul Aebersold
Oct 13, 2012·Frontiers in Cellular and Infection Microbiology·Roy E BarnewallJohn E Bigger
May 3, 2014·PLoS Pathogens·Inger K DamonGrant McFadden

❮ Previous
Next ❯

Citations

Feb 1, 2018·Vaccines·Sharon MelamedNir Paran

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.